KNIMS - The Karolinska Neuroimmunology & Multiple Sclerosis Network
The Karolinska Neuroimmunology & Multiple Sclerosis (KNIMS) network is a collective of neurological clinical and preclinical research scientists working actively to:
(1) provide first-class medical care for individuals with neurological disorders
(2) to understand their underlying pathogenic mechanisms
(3) to develop diagnostic tools and therapeutic modalities for their improved diagnosis and treatment.
Photo: N/AOur Vision
About us
Photo: Martin StenmarkOur Researchers
KNIMS researchers
Photo: N/ANews
KNIMS News
Highlights
KNIMS Research uncovers how Epstein–Barr virus may trigger Multiple Sclerosis (Cell, 2026)
This collaborative study led by KNIMS research groups has identified a key mechanism explaining how the common Epstein–Barr virus (EBV) may contribute to the development of multiple sclerosis (MS).
KNIMS retreat 2025
This second KNIMS retreat gathered nearly 90 people from 18 research groups and teams with an extensive range of scientific competencies in the field of neuroimmunology and served as a platform to foster interaction between researchers and enhance innovative collaborative research projects.
Gonçalo Castelo-Branco awarded prestigious ERC Proof of Concept grant
KNIMS hosted Nobel Symposium 2025
On June 5, 2025, the Karolinska Neuroimmunology & Multiple Sclerosis Network (KNIMS) PIs hosted The Nobel Symposium - Multiple Sclerosis: from molecular mechanisms to disease-modifying treatments.
KNIMS receives the award “Excellence in Neuroscience Annual Reward”
KNIMS distinction was recognized by the “Excellence in Neuroscience Annual Reward (EINAR)” prize awarded during the Clinical Neuroscience Department Day on May 26, 2025.